Pierre Chelle

492 total citations
31 papers, 352 citations indexed

About

Pierre Chelle is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pierre Chelle has authored 31 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 11 papers in Genetics and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pierre Chelle's work include Hemophilia Treatment and Research (25 papers), Blood Coagulation and Thrombosis Mechanisms (13 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers). Pierre Chelle is often cited by papers focused on Hemophilia Treatment and Research (25 papers), Blood Coagulation and Thrombosis Mechanisms (13 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers). Pierre Chelle collaborates with scholars based in Canada, France and United States. Pierre Chelle's co-authors include Andrea N. Edginton, Alfonso Iorio, Alanna McEneny‐King, Paul Malik, B. Tardy-Poncet, Cédric Hermans, Arun Keepanasseril, Gary Foster, Anthony J. Mutsaers and Andre Fleck and has published in prestigious journals such as Blood, Nanoscale and Advanced Science.

In The Last Decade

Pierre Chelle

31 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Chelle Canada 12 235 76 44 32 28 31 352
Evan C. Chen United States 10 151 0.6× 53 0.7× 88 2.0× 18 0.6× 18 0.6× 32 265
Sara Zanardelli United Kingdom 6 280 1.2× 92 1.2× 109 2.5× 13 0.4× 34 1.2× 7 481
Luís Borque Spain 11 177 0.8× 168 2.2× 26 0.6× 10 0.3× 24 0.9× 17 329
I. Steneker Netherlands 13 157 0.7× 42 0.6× 48 1.1× 17 0.5× 18 0.6× 17 331
Hongman Xue China 8 123 0.5× 20 0.3× 78 1.8× 21 0.7× 14 0.5× 51 272
Ingo Ganzleben Germany 7 40 0.2× 23 0.3× 74 1.7× 3 0.1× 22 0.8× 15 270
Jamil Azzi United States 6 84 0.4× 25 0.3× 94 2.1× 9 0.3× 25 0.9× 9 346
Yang Cong China 9 39 0.2× 33 0.4× 174 4.0× 38 1.2× 133 4.8× 26 373
Veerle Mondelaers Belgium 11 25 0.1× 28 0.4× 106 2.4× 7 0.2× 72 2.6× 19 415
Ying Fei Li United States 7 56 0.2× 27 0.4× 30 0.7× 6 0.2× 16 0.6× 13 153

Countries citing papers authored by Pierre Chelle

Since Specialization
Citations

This map shows the geographic impact of Pierre Chelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Chelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Chelle more than expected).

Fields of papers citing papers by Pierre Chelle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Chelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Chelle. The network helps show where Pierre Chelle may publish in the future.

Co-authorship network of co-authors of Pierre Chelle

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Chelle. A scholar is included among the top collaborators of Pierre Chelle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Chelle. Pierre Chelle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keyvani, Fatemeh, Mohammad Soltani, Yusheng Zhao, et al.. (2024). Integrated Electrochemical Aptamer Biosensing and Colorimetric pH Monitoring via Hydrogel Microneedle Assays for Assessing Antibiotic Treatment. Advanced Science. 11(41). e2309027–e2309027. 22 indexed citations
2.
3.
Matino, Davide, Pierre Chelle, Shannon Jackson, et al.. (2023). OC 24.1 Effect of the Type of F9 Mutation on the Pharmacokinetic Profile of Patients with Hemophilia B Treated with Extended Half-Life FIX Concentrates. Research and Practice in Thrombosis and Haemostasis. 7. 100443–100443. 1 indexed citations
4.
Tardy, Brigitte, Thierry Lambert, Marc Trossaërt, et al.. (2022). Revised terminal half‐life of nonacog alfa as derived from extended sampling data: A real‐world study involving 64 haemophilia B patients on nonacog alfa regular prophylaxis. Haemophilia. 28(4). 542–547. 4 indexed citations
5.
Chelle, Pierre, Alfonso Iorio, & Andrea N. Edginton. (2022). A personalized limited sampling approach to better estimate terminal half‐life of FVIII concentrates. Journal of Thrombosis and Haemostasis. 20(9). 2012–2021. 1 indexed citations
6.
Iserman, Emma, Pierre Chelle, Federico Germini, et al.. (2022). Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia. HemaSphere. 6(4). e694–e694. 1 indexed citations
7.
Chelle, Pierre, et al.. (2021). External qualification of the Web‐Accessible Population Pharmacokinetic Service–Hemophilia (WAPPS‐Hemo) models for octocog alfa using real patient data. Research and Practice in Thrombosis and Haemostasis. 5(7). e12599–e12599. 3 indexed citations
8.
Iserman, Emma, Pierre Chelle, Federico Germini, et al.. (2021). Terminal half‐life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database. Journal of Thrombosis and Haemostasis. 19(8). 1896–1906. 16 indexed citations
9.
Bouchnita, Anass, Pierre Chelle, Martine Marion, et al.. (2021). Patient-Specific Modelling of Blood Coagulation. Bulletin of Mathematical Biology. 83(5). 50–50. 17 indexed citations
10.
Pouplard, Claire, Laurent Sattler, Valérie Eschwège, et al.. (2020). Multicentre pharmacokinetic evaluation of rFVIII‐Fc (efmoroctocog alfa) in a real life and comparison with non‐extended half‐life FVIII concentrates. Haemophilia. 26(2). 282–289. 8 indexed citations
11.
Malik, Paul, Shruti Nambiar, Pierre Chelle, et al.. (2019). Biodistribution and Physiologically-Based Pharmacokinetic Modeling of Gold Nanoparticles in Mice with Interspecies Extrapolation. Pharmaceutics. 11(4). 179–179. 42 indexed citations
12.
Chelle, Pierre, Pauline Damien, Michèle Piot, et al.. (2019). Tissue factor pathway inhibitor is the main determinant of thrombin generation in haemophilic patients. Haemophilia. 25(2). 343–348. 15 indexed citations
13.
Carção, Manuel, Pierre Chelle, Massimo Morfini, et al.. (2019). Comparative pharmacokinetics of two extended half‐life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference?. Journal of Thrombosis and Haemostasis. 17(7). 1085–1096. 38 indexed citations
14.
Chelle, Pierre, Cindy H. T. Yeung, Stacy E. Croteau, et al.. (2019). Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup. Clinical Pharmacokinetics. 59(2). 245–256. 18 indexed citations
15.
McEneny‐King, Alanna, Pierre Chelle, Gary Foster, et al.. (2019). Development and evaluation of a generic population pharmacokinetic model for standard half-life factor VIII for use in dose individualization. Journal of Pharmacokinetics and Pharmacodynamics. 46(5). 411–426. 29 indexed citations
16.
Iorio, Alfonso, et al.. (2019). A comparison of methods for prediction of pharmacokinetics across factor concentrate switching in hemophilia patients. Thrombosis Research. 184. 31–37. 3 indexed citations
17.
Tokarev, A., et al.. (2019). Clustering of Thrombin Generation Test Data Using a Reduced Mathematical Model of Blood Coagulation. Acta Biotheoretica. 68(1). 21–43. 11 indexed citations
18.
Chelle, Pierre, et al.. (2018). Prediction of individual factor VIII or IX level for the correction of thrombin generation in haemophilic patients. Haemophilia. 24(6). 995–1001. 11 indexed citations
19.
Chelle, Pierre, et al.. (2018). Evaluation and Calibration of In Silico Models of Thrombin Generation Using Experimental Data from Healthy and Haemophilic Subjects. Bulletin of Mathematical Biology. 80(8). 1989–2025. 8 indexed citations
20.
McEneny‐King, Alanna, Pierre Chelle, Alfonso Iorio, & Andrea N. Edginton. (2018). The effect of unmeasurable endogenous plasma factor activity levels on factor VIII dosing in patients with severe hemophilia A. Thrombosis Research. 170. 53–59. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evan C. Chen Breakdown of academic impact, for papers by Sara Zanardelli Breakdown of academic impact, for papers by Luís Borque Breakdown of academic impact, for papers by I. Steneker Breakdown of academic impact, for papers by Hongman Xue Breakdown of academic impact, for papers by Ingo Ganzleben Breakdown of academic impact, for papers by Jamil Azzi Breakdown of academic impact, for papers by Yang Cong Breakdown of academic impact, for papers by Veerle Mondelaers Breakdown of academic impact, for papers by Ying Fei Li
Rankless by CCL
2026